APA

Gamé X., Castel-Lacanal E., Bentaleb Y., Thiry-Escudié I., De Boissezon X., Malavaud B., Marque P. & Rischmann P. (20080513). Botulinum toxin A detrusor injections in patients with neurogenic detrusor overactivity significantly decrease the incidence of symptomatic urinary tract infections. : European urology.

Chicago

Gamé Xavier, Castel-Lacanal Evelyne, Bentaleb Youssef, Thiry-Escudié Isabelle, De Boissezon Xavier, Malavaud Bernard, Marque Philippe and Rischmann Pascal. 20080513. Botulinum toxin A detrusor injections in patients with neurogenic detrusor overactivity significantly decrease the incidence of symptomatic urinary tract infections. : European urology.

Harvard

Gamé X., Castel-Lacanal E., Bentaleb Y., Thiry-Escudié I., De Boissezon X., Malavaud B., Marque P. and Rischmann P. (20080513). Botulinum toxin A detrusor injections in patients with neurogenic detrusor overactivity significantly decrease the incidence of symptomatic urinary tract infections. : European urology.

MLA

Gamé Xavier, Castel-Lacanal Evelyne, Bentaleb Youssef, Thiry-Escudié Isabelle, De Boissezon Xavier, Malavaud Bernard, Marque Philippe and Rischmann Pascal. Botulinum toxin A detrusor injections in patients with neurogenic detrusor overactivity significantly decrease the incidence of symptomatic urinary tract infections. : European urology. 20080513.